Brazil and GSK invest in new vaccine partnership
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline and the Brazilian government are to invest €70 million (R$183.7 million) on developing new vaccines for dengue fever, yellow fever and malaria, Brazil's health minister, José Gomes Temporão, said.